Vertex Pharmaceuticals · Total Non-Current Liabilities

VRTX Total Non-Current Liabilities

Latest reported$3.24Bperiod endingJun 30, 2026

VRTX Quarterly Total Non-Current Liabilities ($2.40M → $3.24B)

Quarterly total non-current liabilities

High-resolution chart · PNG

VRTX total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Total Non-Current Liabilities — Quarterly (USD)
Period ending	Total Non-Current Liabilities (USD)
Jun 30, 2026	3,237,500,000
Mar 31, 2026	3,241,900,000
Dec 31, 2025	3,615,800,000
Sep 30, 2025	3,068,200,000
Jun 30, 2025	2,722,900,000
Mar 31, 2025	2,601,000,000
Dec 31, 2024	2,559,000,000
Sep 30, 2024	2,636,200,000
Jun 30, 2024	1,810,200,000
Mar 31, 2024	1,574,900,000
Dec 31, 2023	1,602,400,000
Sep 30, 2023	1,614,000,000
Jun 30, 2023	1,526,900,000
Mar 31, 2023	1,515,700,000
Dec 31, 2022	1,496,100,000
Sep 30, 2022	1,067,500,000
Jun 30, 2022	1,092,500,000
Mar 31, 2022	1,168,900,000
Dec 31, 2021	1,190,500,000
Sep 30, 2021	1,173,773,000
Jun 30, 2021	1,188,842,000
Mar 31, 2021	1,190,755,000
Dec 31, 2020	1,187,500,000
Sep 30, 2020	1,164,134,000
Jun 30, 2020	898,485,000
Mar 31, 2020	892,797,000
Dec 31, 2019	898,394,000
Sep 30, 2019	872,265,000
Jun 30, 2019	704,286,000
Mar 31, 2019	713,333,000
Dec 31, 2018	690,403,000
Sep 30, 2018	693,851,000
Jun 30, 2018	693,203,000
Mar 31, 2018	694,841,000
Dec 31, 2017	696,448,000
Sep 30, 2017	684,342,000
Jun 30, 2017	792,957,000
Mar 31, 2017	774,114,000
Dec 31, 2016	766,059,000
Sep 30, 2016	678,459,000
Jun 30, 2016	757,282,000
Mar 31, 2016	819,667,000
Dec 31, 2015	898,792,000
Sep 30, 2015	982,302,000
Jun 30, 2015	952,034,000
Mar 31, 2015	865,852,000
Dec 31, 2014	870,242,000
Sep 30, 2014	878,003,000
Jun 30, 2014	582,578,000
Mar 31, 2014	592,730,000
Dec 31, 2013	564,807,000
Sep 30, 2013	726,193,000
Jun 30, 2013	693,228,000
Mar 31, 2013	1,046,635,000
Dec 31, 2012	1,130,812,000
Sep 30, 2012	1,047,346,000
Jun 30, 2012	981,539,000
Mar 31, 2012	883,451,000
Dec 31, 2011	883,456,000
Sep 30, 2011	812,203,000
Jun 30, 2011	834,952,000
Mar 31, 2011	730,620,000
Dec 31, 2010	746,690,000
Sep 30, 2010	927,166,000
Jun 30, 2010	534,691,000
Mar 31, 2010	568,150,000
Dec 31, 2009	574,259,000
Sep 30, 2009	733,381,000
Jun 30, 2009	527,139,000
Mar 31, 2009	679,733,000
Dec 31, 2008	525,041,000
Sep 30, 2008	537,198,000
Jun 30, 2008	547,986,000
Mar 31, 2008	411,927,000
Dec 31, 2007	130,903,000
Sep 30, 2007	137,405,000
Jun 30, 2007	143,583,000
Mar 31, 2007	159,208,000
Dec 31, 2006	164,630,000
Sep 30, 2006	232,887,000
Jun 30, 2006	341,747,000
Mar 31, 2006	209,503,000
Dec 31, 2005	209,579,000
Sep 30, 2005	295,453,000
Jun 30, 2005	335,959,000
Mar 31, 2005	344,553,000
Dec 31, 2004	356,267,000
Sep 30, 2004	365,596,000
Jun 30, 2004	376,307,000
Mar 31, 2004	391,252,000
Dec 31, 2003	392,499,000
Sep 30, 2003	391,569,000
Jun 30, 2003	387,418,000
Mar 31, 2003	383,746,000
Dec 31, 2002	372,542,000
Sep 30, 2002	364,068,000
Jun 30, 2002	361,508,000
Mar 31, 2002	359,854,000
Dec 31, 2001	358,227,000
Sep 30, 2001	354,185,000